Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
yiqi wenyang huoxue
- Development stage
- Unknown
- Lead developer
- Affiliated Hospital of Jiangxi University of Chinese Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Yiqi Wenyang Huoxue is a Traditional Chinese Medicine (TCM) formulation developed by the Affiliated Hospital of Jiangxi University of Chinese Medicine, primarily indicated for the treatment of angina pectoris and coronary heart disease. The formula is designed based on the TCM principles of supplementing Qi, warming Yang, and promoting blood circulation to resolve stasis. It typically contains a combination of herbs such as Astragalus membranaceus (Huangqi), Panax ginseng (Renshen), and Salvia miltiorrhiza (Danshen), though specific compositions may vary by study. Its mechanism of action involves improving myocardial blood flow, reducing oxidative stress, and modulating inflammatory pathways to alleviate chest pain and improve cardiac function. It is often utilized as a hospital-made preparation (医院制剂) and has been evaluated in clinical research settings in China.
- Other names
- Yiqi Wenyang Huoxue DecoctionYiqi Wenyang Huoxue Granules益气温阳活血方
02
Targets
TLR4 (Toll-like receptor 4)IL-6 (Interleukin 6)TNFA (Tumor necrosis factor alpha (soluble))IL1B (Interleukin-1 beta)
Beyond the preview
Go deeper on yiqi wenyang huoxue.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on yiqi wenyang huoxue.